Ardeshir Khademi: A Clinical Lesson on Thrombophilia, Silent Infarcts, and Asking the Right Questions
Ardeshir Khademi, Founder and Medical Director at Countryside Neurology, posted on LinkedIn:
” ‘Did you have stroke in the past ?’
‘No, never’
Today, I saw a woman in her 50s whose MRI showed two old cortical infarcts — not tiny lacunes, but clear evidence of past strokes.
When I asked if she’d ever had a stroke, she said:
‘No’
She truly didn’t know. No documented event. No hospitalization. Just silent damage, revealed years later.
She mentioned being Factor V Leiden positive, which usually causes venous clots — not the arterial ones that lead to stroke.
That inconsistency made me ask more questions.
Then came the key detail:
Her sister had antiphospholipid antibody syndrome (APS) — a condition that can cause arterial thrombosis and stroke.
Lesson:
Not all thrombophilias (clotting disorders) are created equal.
• Factor V Leiden → venous
• Antiphospholipid syndrome → arterial ± venous
And sometimes, the brain quietly records a history the patient never knew.
Have you ever found “silent” strokes that rewrote a patient’s story?

— Ardeshir Khademi
Neurology | Brain Health
Countryside Neurology | NeuroVista Insights”
Stay informed with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian